CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23 | -17.9% | 504 | +2.6% | 0.01% | -28.6% |
| Q2 2023 | $28 | +12.0% | 491 | -12.0% | 0.01% | +16.7% |
| Q1 2023 | $25 | +19.0% | 558 | +5.7% | 0.01% | 0.0% |
| Q4 2022 | $21 | -99.9% | 528 | +25.4% | 0.01% | -25.0% |
| Q3 2022 | $28,000 | -6.7% | 421 | -15.6% | 0.01% | -11.1% |
| Q2 2022 | $30,000 | 0.0% | 499 | +4.0% | 0.01% | 0.0% |
| Q1 2022 | $30,000 | -16.7% | 480 | +2.1% | 0.01% | -25.0% |
| Q4 2021 | $36,000 | -18.2% | 470 | +18.7% | 0.01% | -55.6% |
| Q3 2021 | $44,000 | -33.3% | 396 | -3.4% | 0.03% | -40.0% |
| Q2 2021 | $66,000 | +13.8% | 410 | -14.2% | 0.04% | +2.3% |
| Q1 2021 | $58,000 | -30.1% | 478 | -12.3% | 0.04% | -31.2% |
| Q4 2020 | $83,000 | +27.7% | 545 | -29.9% | 0.06% | +18.5% |
| Q3 2020 | $65,000 | +20.4% | 778 | +6.6% | 0.05% | +20.0% |
| Q2 2020 | $54,000 | +74.2% | 730 | 0.0% | 0.04% | +40.6% |
| Q1 2020 | $31,000 | -18.4% | 730 | +17.6% | 0.03% | -59.0% |
| Q4 2019 | $38,000 | +65.2% | 621 | +9.5% | 0.08% | +56.0% |
| Q3 2019 | $23,000 | -11.5% | 567 | +3.8% | 0.05% | -20.6% |
| Q2 2019 | $26,000 | +160.0% | 546 | +96.4% | 0.06% | +31.2% |
| Q1 2019 | $10,000 | – | 278 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |